ZIEXTENZO
Live / Registered — Registered — Sections 8 & 15 accepted and acknowledged (as of 12 Jul 2025)
What this means for you
Registered since 25 Jun 2019. The owner can stop confusingly similar uses in the classes it covers.
Record
- Serial number
- 88229972
- Registration number
- 5787873
- Mark type
- Stylized text
- Filed
- 14 Dec 2018
- Published for opposition
- 09 Apr 2019
- Registered
- 25 Jun 2019
- Attorney of record
- Maury M. Tepper, III
Goods and services
- Class 005 — Pharmaceuticals: Pharmaceutical preparations for the treatment of cancer and related symptoms
Owner
- SANDOZ AG, BASEL, CH
- Novartis AG, Basel, CH
- Novartis AG, Basel, CH
- Novartis AG, Basel, CH
Prosecution history
- 12 Jul 2025 — NOTICE OF ACCEPTANCE OF SEC. 8 & 15 - E-MAILED
- 12 Jul 2025 — REGISTERED - SEC. 8 (6-YR) ACCEPTED & SEC. 15 ACK.
- 12 Jul 2025 — CASE ASSIGNED TO POST REGISTRATION PARALEGAL
- 14 Mar 2025 — TEAS SECTION 8 & 15 RECEIVED
- 25 Jun 2024 — COURTESY REMINDER - SEC. 8 (6-YR) E-MAILED
- 06 Dec 2023 — AUTOMATIC UPDATE OF ASSIGNMENT OF OWNERSHIP
- 25 Jun 2019 — REGISTERED-PRINCIPAL REGISTER
- 09 Apr 2019 — OFFICIAL GAZETTE PUBLICATION CONFIRMATION E-MAILED
- 09 Apr 2019 — PUBLISHED FOR OPPOSITION
- 20 Mar 2019 — NOTIFICATION OF NOTICE OF PUBLICATION E-MAILED
- 06 Mar 2019 — LAW OFFICE PUBLICATION REVIEW COMPLETED
- 04 Mar 2019 — APPROVED FOR PUB - PRINCIPAL REGISTER
- 04 Mar 2019 — TEAS/EMAIL CORRESPONDENCE ENTERED
- 04 Mar 2019 — CORRESPONDENCE RECEIVED IN LAW OFFICE
- 28 Feb 2019 — ASSIGNED TO LIE